Koyfin Home > Directory > Health Care > Pieris Pharma > Levered Free Cash Flow (FCF)

Pieris Pharma Levered Free Cash Flow (FCF) Chart (PIRS)

Pieris Pharma annual/quarterly Levered Free Cash Flow (FCF) from 2014 to 2020.
  • Pieris Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2020 was $3m a 482.39% increase of 16m year over year
  • Pieris Pharma Levered Free Cash Flow (FCF) for the last 12 months ending September 09, 2020 was $-26m a -47.32% increase of 12m year over year
  • Pieris Pharma Annual Levered Free Cash Flow (FCF) for 2019 was $-38m a 91.49% decrease of -35m from 2018
  • Pieris Pharma Annual Levered Free Cash Flow (FCF) for 2018 was $-3m a 586.47% decrease of -19m from 2017
  • Pieris Pharma Annual Levered Free Cash Flow (FCF) for 2017 was $16m a 149.97% increase of 24m from 2016
Other Cash Flow Metrics:
  • Pieris Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $-14m a 67.31% decrease of -10m year over year
  • Pieris Pharma Total Revenue for the quarter ending September 09, 2018 was $8m a -117.52% decrease of -10m year over year
View Chart On Koyfin

Quarterly PIRS Levered Free Cash Flow (FCF) Data

09/2020$3m
06/2020$-9m
03/2020$-10m
12/2019$-13m
09/2019$-3m
06/2019$-7m
03/2019$-19m
12/2018$3m
09/2018$-21m
06/2018$-3m

Annual PIRS Levered Free Cash Flow (FCF) Data

2019$-38m
2018$-3m
2017$16m
2016$-8m
2015$-7m
2014$-5m
2013$-3m